question_key
stringlengths 16
58
| relation
stringlengths 6
48
| question_template
stringlengths 29
90
| subject_cui
stringlengths 8
8
| subject_label
stringlengths 4
160
| correct_object_cui
stringlengths 8
8
| correct_object_label
stringlengths 3
204
| opa
stringlengths 7
150
| opb
stringlengths 3
204
| opc
stringlengths 4
221
| opd
stringlengths 5
166
| cop
int64 0
3
|
---|---|---|---|---|---|---|---|---|---|---|---|
C2981613::disease_excludes_finding
|
disease_excludes_finding
|
Which finding is specifically excluded in the diagnosis of disease {subj}?
|
C2981613
|
Stage IIIA Digestive System Neuroendocrine Tumor AJCC v7
|
C0333868
|
Severe cytologic atypia
|
Neurofibrillary degeneration (morphologic abnormality)
|
Trisomy 18 (morphologic abnormality)
|
Severe cytologic atypia
|
Squamous metaplasia
| 2 |
C5420536::disease_excludes_finding
|
disease_excludes_finding
|
Which finding is specifically excluded in the diagnosis of disease {subj}?
|
C5420536
|
Advanced Cervical Adenosquamous Carcinoma
|
C0277565
|
Local disease
|
Regional enteritis
|
Basal pneumonia
|
Local disease
|
Nodal block
| 2 |
C4725707::disease_excludes_normal_cell_origin
|
disease_excludes_normal_cell_origin
|
Which normal cell origin is specifically excluded in the disease {subj}?
|
C4725707
|
Extracavitary Primary Effusion Lymphoma
|
C0032112
|
Plasma Cells
|
Phagocytes
|
Cells.HLA-B27
|
Plasma Cells
|
Plasma cells.abnormal marker pattern
| 2 |
C0079773::disease_excludes_normal_cell_origin
|
disease_excludes_normal_cell_origin
|
Which normal cell origin is specifically excluded in the disease {subj}?
|
C0079773
|
Lymphoma, T-Cell, Cutaneous
|
C0887899
|
Myeloid Cells
|
Myeloid precursor cell
|
Myeloid Cells
|
Pre-B Lymphocytes
|
Blood Cells
| 1 |
C5855556::disease_excludes_normal_cell_origin
|
disease_excludes_normal_cell_origin
|
Which normal cell origin is specifically excluded in the disease {subj}?
|
C5855556
|
IgM Monoclonal Gammopathy of Undetermined Significance, Plasma Cell Type
|
C1516097
|
B lymphoblast
|
Monocytoid B-Lymphocyte
|
CYIG+ lymphocyte
|
B lymphoblast
|
Activated B-Lymphocyte
| 2 |
C1335388::disease_excludes_normal_tissue_origin
|
disease_excludes_normal_tissue_origin
|
Which normal tissue origin is specifically excluded in the disease {subj}?
|
C1335388
|
Peripheral Intraneural Angiosarcoma
|
C0014609
|
Epithelium
|
Entire respiratory epithelium
|
Bile Duct Epithelium
|
Epidermis
|
Epithelium
| 3 |
C5554988::disease_excludes_normal_tissue_origin
|
disease_excludes_normal_tissue_origin
|
Which normal tissue origin is specifically excluded in the disease {subj}?
|
C5554988
|
Unresectable Myxofibrosarcoma
|
C0014609
|
Epithelium
|
Epithelium
|
Epidermis proper
|
Epidermal Ridge
|
Transitional epithelium
| 0 |
C0206717::disease_excludes_normal_tissue_origin
|
disease_excludes_normal_tissue_origin
|
Which normal tissue origin is specifically excluded in the disease {subj}?
|
C0206717
|
Olfactory Neuroblastoma
|
C1708239
|
Germinal Layer
|
Structure of germinal epithelium of ovary
|
Basal Domain of the Epithelium
|
Peyer Patch Germinal Center
|
Germinal Layer
| 3 |
C4520724::disease_excludes_primary_anatomic_site
|
disease_excludes_primary_anatomic_site
|
Which primary anatomic site is specifically excluded in the disease {subj}?
|
C4520724
|
Stage III Adult Soft Tissue Sarcoma AJCC v7
|
C0262950
|
Skeletal bone
|
Skeletal muscle structure of head
|
Skeleton of forearm
|
Skeletal bone
|
Bone structure of forearm
| 2 |
C1332903::disease_excludes_primary_anatomic_site
|
disease_excludes_primary_anatomic_site
|
Which primary anatomic site is specifically excluded in the disease {subj}?
|
C1332903
|
Cerebellar Vermis Medulloblastoma
|
C0037925
|
Spinal Cord
|
Spinal cord posterior horn
|
Spinal nerve root NEC
|
Spinal Cord
|
Spinal cord tissue structure
| 2 |
C1516417::disease_excludes_primary_anatomic_site
|
disease_excludes_primary_anatomic_site
|
Which primary anatomic site is specifically excluded in the disease {subj}?
|
C1516417
|
Cervical Large Cell Neuroendocrine Carcinoma
|
C0460004
|
Head and neck structure
|
External nose structure
|
Chest and abdominal vessels
|
Upper jaw region
|
Head and neck structure
| 3 |
C5206840::disease_has_abnormal_cell
|
disease_has_abnormal_cell
|
Which abnormal cell type is characteristic of the disease {subj}?
|
C5206840
|
Unresectable Oropharyngeal Squamous Cell Carcinoma
|
C1514101
|
Neoplastic Squamous Cell
|
Neoplastic Cell
|
Primitive neuroblastic cell
|
Lymphosarcoma cell
|
Neoplastic Squamous Cell
| 3 |
C2212014::disease_has_abnormal_cell
|
disease_has_abnormal_cell
|
Which abnormal cell type is characteristic of the disease {subj}?
|
C2212014
|
Ovarian Mucinous Adenocarcinofibroma
|
C0334227
|
Tumor cells, malignant
|
Entire endometrial glandular cell
|
Tumor cells, malignant
|
Vacuolated Malignant Fibroblast
|
Neoplastic Polygonal Cell
| 1 |
C2825773::disease_has_abnormal_cell
|
disease_has_abnormal_cell
|
Which abnormal cell type is characteristic of the disease {subj}?
|
C2825773
|
Malignant Epithelioid Cell Type Gastrointestinal Stromal Tumor
|
C1514104
|
Neoplastic Stromal Cell
|
Endocrine-Stromal Cell
|
Primitive neuroblastic cell
|
Neoplastic Epithelial Polygonal Cell
|
Neoplastic Stromal Cell
| 3 |
C2347926::disease_has_associated_anatomic_site
|
disease_has_associated_anatomic_site
|
Which anatomic site is associated with the disease {subj}?
|
C2347926
|
Refractory Spinal Cord Neoplasm
|
C0037925
|
Spinal Cord
|
Spinal nerve root S1
|
Spinal Cord
|
Spinal cord posterior horn
|
Cervical Spinal Nerve Root
| 1 |
C0033375::disease_has_associated_anatomic_site
|
disease_has_associated_anatomic_site
|
Which anatomic site is associated with the disease {subj}?
|
C0033375
|
Prolactinoma
|
C0149543
|
Base of skull structure
|
Base of skull structure
|
Orbital complex of bones - floor
|
Base of cochlear canal
|
Base of cochlear duct
| 0 |
C1520094::disease_has_associated_anatomic_site
|
disease_has_associated_anatomic_site
|
Which anatomic site is associated with the disease {subj}?
|
C1520094
|
Vulvar Sebaceous Carcinoma
|
C1261210
|
Reproductive system
|
Reproductive system
|
Skeletal system
|
Arterial system
|
Digestive system subdivision
| 0 |
C0279748::disease_has_associated_disease
|
disease_has_associated_disease
|
Which other disease is associated with the disease {subj}?
|
C0279748
|
Undifferentiated carcinoma of nasopharynx
|
C0042769
|
Virus Diseases
|
B Virus Infection
|
Flavivirus Infections
|
Virus Diseases
|
Coronaviridae Infections
| 2 |
C1335509::disease_has_associated_disease
|
disease_has_associated_disease
|
Which other disease is associated with the disease {subj}?
|
C1335509
|
Prostate Kaposi Sarcoma
|
C0042769
|
Virus Diseases
|
B Virus Infection
|
Filoviridae Infections
|
Virus Diseases
|
Pestivirus Infections
| 2 |
C2986686::disease_has_associated_disease
|
disease_has_associated_disease
|
Which other disease is associated with the disease {subj}?
|
C2986686
|
Ann Arbor Stage IV AIDS-Related Lymphoma
|
C0009450
|
Communicable Diseases
|
Immune System Diseases
|
Opportunistic Infections
|
Communicable Diseases
|
Pneumonia in bacterial diseases classified elsewhere
| 2 |
C0302592::disease_has_associated_gene
|
disease_has_associated_gene
|
Which gene is associated with the disease {subj}?
|
C0302592
|
Cervix carcinoma
|
C2826017
|
MIR218-1 wt Allele
|
MIR218-1 wt Allele
|
MIR373 wt Allele
|
MIR191 wt Allele
|
MIR135B wt Allele
| 0 |
C0279628::disease_has_associated_gene
|
disease_has_associated_gene
|
Which gene is associated with the disease {subj}?
|
C0279628
|
Adenocarcinoma Of Esophagus
|
C1332804
|
CTSB gene
|
LTB gene
|
CTSB gene
|
SPIB gene
|
CTNS gene
| 1 |
C0002395::disease_has_associated_gene
|
disease_has_associated_gene
|
Which gene is associated with the disease {subj}?
|
C0002395
|
Alzheimer's Disease
|
C1705380
|
ZFYVE9 wt Allele
|
WDFY2 wt Allele
|
SIGLEC9 wt Allele
|
ARHGEF10 wt Allele
|
ZFYVE9 wt Allele
| 3 |
C5238468::disease_has_finding
|
disease_has_finding
|
Which finding is characteristic of the disease {subj}?
|
C5238468
|
Locally Advanced Neuroendocrine Neoplasm
|
C0277565
|
Local disease
|
Disseminated scars
|
Burn shock
|
Local disease
|
Bone destruction
| 2 |
C4764032::disease_has_finding
|
disease_has_finding
|
Which finding is characteristic of the disease {subj}?
|
C4764032
|
Recurrent B-Cell Prolymphocytic Leukemia
|
C0277556
|
Recurrent disease
|
Recurrent phimosis
|
Recurrent disease
|
Recurrent infections, mild
|
Relapsing Fever
| 1 |
C1335035::disease_has_finding
|
disease_has_finding
|
Which finding is characteristic of the disease {subj}?
|
C1335035
|
Non-Destructive Post-Transplant Lymphoproliferative Disorder
|
C0021051
|
Immunologic Deficiency Syndromes
|
Immunologic Deficiency Syndromes
|
Hyper-IgM Immunodeficiency Syndrome, Type 1
|
Simian Acquired Immunodeficiency Syndrome
|
Immune System Diseases
| 0 |
C0677689::disease_has_molecular_abnormality
|
disease_has_molecular_abnormality
|
Which molecular abnormality is characteristic of the disease {subj}?
|
C0677689
|
Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma
|
C1516672
|
Clonal Immunoglobulin Gene Rearrangement
|
Absence of Biallelic TCRgamma Deletion
|
Clonal Immunoglobulin Gene Rearrangement
|
FEV Gene Rearrangement
|
IGH Gene Rearrangement
| 1 |
C5670614::disease_has_molecular_abnormality
|
disease_has_molecular_abnormality
|
Which molecular abnormality is characteristic of the disease {subj}?
|
C5670614
|
Embryonal Tumor with Multilayered Rosettes, DICER1-Mutated
|
C4528702
|
DICER1 Gene Mutation
|
Deleterious DICER1 Gene Mutation
|
DICER1 Gene Mutation
|
DOT1L Gene Mutation
|
DIS3 Gene Mutation
| 1 |
C0281700::disease_has_molecular_abnormality
|
disease_has_molecular_abnormality
|
Which molecular abnormality is characteristic of the disease {subj}?
|
C0281700
|
Stage I Childhood Burkitt Lymphoma
|
C1516673
|
Clonal Immunoglobulin Heavy Chain Gene Rearrangement
|
Absence of Biallelic TCRgamma Deletion
|
IGK Gene Rearrangement
|
T-Cell Receptor Gene Rearrangement
|
Clonal Immunoglobulin Heavy Chain Gene Rearrangement
| 3 |
C5669728::disease_has_normal_cell_origin
|
disease_has_normal_cell_origin
|
From which normal cell type does the disease {subj} originate?
|
C5669728
|
Extramedullary Disease in Multiple Myeloma Involving the Skin
|
C1511241
|
Bone Marrow-Homing Plasma Cell
|
Bone Marrow-Homing Plasma Cell
|
Mobilized Peripheral Blood Stem Cell
|
Neoplastic Medium-Sized Lymphocyte
|
Neoplastic Small to Medium-Sized B-Lymphocyte Resembling a Centrocyte
| 0 |
C4682696::disease_has_normal_cell_origin
|
disease_has_normal_cell_origin
|
From which normal cell type does the disease {subj} originate?
|
C4682696
|
Stage IIB Penile Cancer AJCC v8
|
C0014597
|
Epithelial Cells
|
Ciliated epithelial cell
|
Epithelial Cells
|
Endocrine Cells
|
Malignant Myoepithelial Cell
| 1 |
C5855486::disease_has_normal_cell_origin
|
disease_has_normal_cell_origin
|
From which normal cell type does the disease {subj} originate?
|
C5855486
|
B Acute Lymphoblastic Leukemia with HLF Rearrangement
|
C0024264
|
Lymphocyte
|
CD105+ lymphocyte
|
HLE+ lymphocyte
|
Lymphocyte
|
B-Lymphocytes, Regulatory
| 2 |
C3146256::disease_has_normal_tissue_origin
|
disease_has_normal_tissue_origin
|
From which normal tissue does the disease {subj} originate?
|
C3146256
|
Stage II Rectal Cancer AJCC v7
|
C0014609
|
Epithelium
|
Oral epithelium tissue specimen
|
Stratified squamous epithelium
|
Epidermal basement zone
|
Epithelium
| 3 |
C4727196::disease_has_normal_tissue_origin
|
disease_has_normal_tissue_origin
|
From which normal tissue does the disease {subj} originate?
|
C4727196
|
Recurrent Gastroesophageal Junction Adenocarcinoma
|
C0014609
|
Epithelium
|
Endothelium
|
Epidermal Ridge
|
Epithelium
|
Ductal Epithelium
| 2 |
C1292772::disease_has_normal_tissue_origin
|
disease_has_normal_tissue_origin
|
From which normal tissue does the disease {subj} originate?
|
C1292772
|
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
|
C0229619
|
Hemopoietic tissue
|
All bone marrow of bone organ
|
Hemopoietic tissue
|
Entire transplanted bone marrow
|
Genitourinary lymphoid tissue
| 1 |
C4763829::disease_has_primary_anatomic_site
|
disease_has_primary_anatomic_site
|
What is the primary anatomic site of the disease {subj}?
|
C4763829
|
Metastatic Bladder Plasmacytoid Urothelial Carcinoma
|
C1508753
|
Urinary system
|
Skeletal system.peripheral
|
Articular system
|
Urinary system
|
Entire genitourinary system
| 2 |
C1710249::disease_has_primary_anatomic_site
|
disease_has_primary_anatomic_site
|
What is the primary anatomic site of the disease {subj}?
|
C1710249
|
Superficial Epithelioma with Sebaceous Differentiation
|
C0036505
|
Sebaceous Glands
|
Duct of sebaceous gland
|
Sebaceous Glands
|
Sebaceous lobule
|
Sebaceous gland of areola
| 1 |
C3899978::disease_has_primary_anatomic_site
|
disease_has_primary_anatomic_site
|
What is the primary anatomic site of the disease {subj}?
|
C3899978
|
BCLC Stage C Adult Hepatocellular Carcinoma
|
C0012240
|
Gastrointestinal system
|
Respiratory system subdivision
|
Upper digestive tract NEC
|
Gastrointestinal system
|
Entire digestive system
| 2 |
C4553846::disease_is_stage
|
disease_is_stage
|
For which disease is {subj} a stage?
|
C4553846
|
Stage IV Thyroid Gland Papillary Carcinoma AJCC v8
|
C4683415
|
Differentiated Thyroid Gland Carcinoma 55 Years and Older AJCC v8 Stage
|
Stage I Differentiated Thyroid Gland Carcinoma AJCC v8
|
Stage IVC Differentiated Thyroid Gland Carcinoma AJCC v7
|
Stage I Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7
|
Differentiated Thyroid Gland Carcinoma 55 Years and Older AJCC v8 Stage
| 3 |
C4683425::disease_is_stage
|
disease_is_stage
|
For which disease is {subj} a stage?
|
C4683425
|
Stage II Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8
|
C4683413
|
Differentiated Thyroid Gland Carcinoma Under 55 Years AJCC v8 Stage
|
Stage II Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8
|
Stage I Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8
|
Stage IVB Differentiated Thyroid Gland Carcinoma AJCC v8
|
Differentiated Thyroid Gland Carcinoma Under 55 Years AJCC v8 Stage
| 3 |
C4553875::disease_is_stage
|
disease_is_stage
|
For which disease is {subj} a stage?
|
C4553875
|
Stage IVB Differentiated Thyroid Gland Carcinoma AJCC v8
|
C4683415
|
Differentiated Thyroid Gland Carcinoma 55 Years and Older AJCC v8 Stage
|
Stage I Differentiated Thyroid Gland Carcinoma Under 55 Years AJCC v8
|
Stage II Thyroid Gland Follicular Carcinoma 55 Years and Older AJCC v8
|
Stage II Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8
|
Differentiated Thyroid Gland Carcinoma 55 Years and Older AJCC v8 Stage
| 3 |
C1709312::disease_mapped_to_gene
|
disease_mapped_to_gene
|
Which gene is mapped to the disease {subj}?
|
C1709312
|
Oncocytic Variant Thyroid Gland Papillary Carcinoma
|
C1847162
|
GOLGA5/RET Fusion Gene
|
HMGA2/LHFP Fusion Gene
|
HMGA2/CCNB1IP1 Fusion Gene
|
TFG/NTRK1 Fusion Gene
|
GOLGA5/RET Fusion Gene
| 3 |
C1332471::disease_mapped_to_gene
|
disease_mapped_to_gene
|
Which gene is mapped to the disease {subj}?
|
C1332471
|
Benign Anal Granular Cell Tumor
|
C1412687
|
ATP6AP1 gene
|
NCKAP1 gene
|
ATP6AP1 gene
|
CPA6 gene
|
CPA1 gene
| 1 |
C5854746::disease_mapped_to_gene
|
disease_mapped_to_gene
|
Which gene is mapped to the disease {subj}?
|
C5854746
|
Childhood Acute Myeloid Leukemia with t(5;11)(q35;p15); NUP98-NSD1
|
C1847677
|
NSD1/NUP98 FUSION GENE
|
HOXD11/NUP98 FUSION GENE
|
NSD1/NUP98 FUSION GENE
|
MESDC2/SENP1 FUSION GENE
|
HOXA9/NUP98 FUSION GENE
| 1 |
C1336015::disease_may_have_abnormal_cell
|
disease_may_have_abnormal_cell
|
Which abnormal cell type may be found in the disease {subj}?
|
C1336015
|
Smoldering Adult T-Cell Leukemia/Lymphoma
|
C1514093
|
Neoplastic Small T-Lymphocyte
|
Neoplastic T-Cell Large Granular Lymphocyte
|
Neoplastic Small T-Prolymphocyte
|
Tumor Associated Lymphocyte
|
Neoplastic Small T-Lymphocyte
| 3 |
C5668167::disease_may_have_abnormal_cell
|
disease_may_have_abnormal_cell
|
Which abnormal cell type may be found in the disease {subj}?
|
C5668167
|
Pericardial Primary Effusion Lymphoma
|
C1513927
|
Neoplastic B-Immunoblast
|
Neoplastic Follicle Center B-Cell
|
Neoplastic Granulocyte
|
Neoplastic B-Immunoblast
|
Neoplastic Myeloid Cell
| 2 |
C0855142::disease_may_have_abnormal_cell
|
disease_may_have_abnormal_cell
|
Which abnormal cell type may be found in the disease {subj}?
|
C0855142
|
Nodal marginal zone B-cell lymphoma stage I
|
C1514058
|
Neoplastic Plasma Cell
|
Neoplastic Glial Cell
|
Neoplastic Melanocyte
|
Neoplastic Endocrine Cell
|
Neoplastic Plasma Cell
| 3 |
C0855184::disease_may_have_associated_disease
|
disease_may_have_associated_disease
|
Which other disease may be associated with the disease {subj}?
|
C0855184
|
Testicular choriocarcinoma stage III
|
C0010417
|
Cryptorchidism
|
Indeterminate sex and pseudohermaphroditism
|
Cryptorchidism
|
Opodidymus
|
Hologastroschisis
| 1 |
C5206775::disease_may_have_associated_disease
|
disease_may_have_associated_disease
|
Which other disease may be associated with the disease {subj}?
|
C5206775
|
Refractory Kidney Medullary Carcinoma
|
C0037054
|
Sickle Cell Trait
|
hemoglobinopathy trait SS
|
Sickle Cell Trait
|
Sickle cell arthropathy
|
Sickle cell beta plus thalassemia
| 1 |
C4725616::disease_may_have_associated_disease
|
disease_may_have_associated_disease
|
Which other disease may be associated with the disease {subj}?
|
C4725616
|
Refractory Ovarian Endometrioid Adenocarcinoma
|
C0476089
|
Endometrial Carcinoma
|
Type II Endometrial Adenocarcinoma
|
Recurrent Endometrial Undifferentiated Carcinoma
|
Recurrent Endometrial Endometrioid Adenocarcinoma
|
Endometrial Carcinoma
| 3 |
C1333842::disease_may_have_cytogenetic_abnormality
|
disease_may_have_cytogenetic_abnormality
|
Which cytogenetic abnormality may be present in the disease {subj}?
|
C1333842
|
Grade 3 Cutaneous Follicular Lymphoma
|
C1515604
|
del(6q23)
|
del(6p21)
|
del(6q23)
|
del(8p12p21)
|
del(11q22.3)
| 1 |
C4763841::disease_may_have_cytogenetic_abnormality
|
disease_may_have_cytogenetic_abnormality
|
Which cytogenetic abnormality may be present in the disease {subj}?
|
C4763841
|
Metastatic Bladder Giant Cell Urothelial Carcinoma
|
C1517979
|
Loss of Chromosome 2q
|
Loss of Chromosome 20
|
Chromosome 15q, partial deletion
|
Loss of Chromosome 2q
|
Chromosome 5q31-33 Deletion
| 2 |
C1332997::disease_may_have_cytogenetic_abnormality
|
disease_may_have_cytogenetic_abnormality
|
Which cytogenetic abnormality may be present in the disease {subj}?
|
C1332997
|
Childhood T Lymphoblastic Leukemia/Lymphoma
|
C1515789
|
t(7;9)(q34;q34.3)
|
t(3;3)(q21.3;q26.2)
|
t(7;9)(q34;q34.3)
|
t(13;22)(q22;q13.3)
|
t(1;19)(q23;p13.3)
| 1 |
C1334249::disease_may_have_finding
|
disease_may_have_finding
|
Which finding may be present in the disease {subj}?
|
C1334249
|
Intraductal Micropapillary Breast Carcinoma
|
C0520594
|
Breast Microcalcification
|
Breast Microcalcification
|
Cervical Microglandular Hyperplasia
|
Cortical calcifications
|
Calcified granuloma
| 0 |
C5237826::disease_may_have_finding
|
disease_may_have_finding
|
Which finding may be present in the disease {subj}?
|
C5237826
|
Advanced Colorectal Adenocarcinoma
|
C0024050
|
Lower gastrointestinal hemorrhage
|
Other neonatal gastrointestinal hemorrhage
|
Duodenal hemorrhage
|
Gastrointestinal bleeding neonatal
|
Lower gastrointestinal hemorrhage
| 3 |
C1519915::disease_may_have_finding
|
disease_may_have_finding
|
Which finding may be present in the disease {subj}?
|
C1519915
|
Vaginal Adenosquamous Carcinoma
|
C2979982
|
Vaginal Hemorrhage
|
Vaginal Hemorrhage
|
Hemorrhoidal Hemorrhage
|
Genital hemorrhage
|
Hemorrhage of tunica vaginalis
| 0 |
C1512749::disease_may_have_molecular_abnormality
|
disease_may_have_molecular_abnormality
|
Which molecular abnormality may be present in the disease {subj}?
|
C1512749
|
Invasive Bladder Urothelial Carcinoma with Trophoblastic Differentiation
|
C3266989
|
H-ras gene mutation
|
KRAS Exon 3 Mutation
|
Checkpoint kinase 2 gene mutation
|
NRAS Gene Amplification
|
H-ras gene mutation
| 3 |
C4743673::disease_may_have_molecular_abnormality
|
disease_may_have_molecular_abnormality
|
Which molecular abnormality may be present in the disease {subj}?
|
C4743673
|
Digestive System Small Cell Neuroendocrine Carcinoma
|
C1515171
|
TP53 Gene Inactivation
|
Deleterious TP53 Gene Mutation
|
Inactivating RAD51B Gene Mutation
|
TP53 Gene Inactivation
|
TGFBR2 Gene Inactivation
| 2 |
C1334052::disease_may_have_molecular_abnormality
|
disease_may_have_molecular_abnormality
|
Which molecular abnormality may be present in the disease {subj}?
|
C1334052
|
Human Papillomavirus-Related Cervical Squamous Cell Carcinoma
|
C1512127
|
HER2 gene amplification
|
HER2 gene amplification
|
TERT Deficiency
|
BLyS polymorphism
|
Hypermelanosis due to hormonal factor
| 0 |
C5401025::disposition_of
|
disposition_of
|
Which of the following is {subj} a disposition of?
|
C5401025
|
Estrogen receptor agonist (disposition)
|
C0059668
|
estrone sulfate
|
estrone sulfate
|
butacaine sulfate
|
estradiol valerate compounding powder
|
nomegestrol and estrogen
| 0 |
C5434066::disposition_of
|
disposition_of
|
Which of the following is {subj} a disposition of?
|
C5434066
|
Alpha-adrenergic and beta-adrenergic agonist (disposition)
|
C0304430
|
pseudoephedrine hydrochloride
|
pseudoephedrine hydrochloride
|
aminacrine hydrochloride
|
Methscopolamine nitrate + pseudoephedrine hydrochloride
|
cinnamedrine hydrochloride
| 0 |
C3853002::disposition_of
|
disposition_of
|
Which of the following is {subj} a disposition of?
|
C3853002
|
Androgen Synthesis Inhibitors
|
C5686001
|
Steroidal androgen synthesis inhibitor
|
testosterone cypionate compounding powder
|
Calcium antacid compound combinations
|
Steroidal androgen synthesis inhibitor
|
Testosterone esters
| 2 |
C0185622::do_not_code_with
|
do_not_code_with
|
Which of the following should not be coded with {subj}?
|
C0185622
|
Open treatment of fracture of orbit, except blowout; with implant
|
C1609555
|
Irrigation of implanted venous access device for drug delivery systems
|
Revision of implantable venous access port
|
Irrigation of implanted venous access device for drug delivery systems
|
Implantation of electronic stimulator into urinary bladder
|
Fluoroscopy guided removal of implantable venous access device
| 1 |
C0197419::do_not_code_with
|
do_not_code_with
|
Which of the following should not be coded with {subj}?
|
C0197419
|
Corneal wedge resection for correction of surgically induced astigmatism
|
C1609555
|
Irrigation of implanted venous access device for drug delivery systems
|
Irrigation of ventricular catheter
|
Accessing of implantable venous access port
|
Implantation of spinal drug delivery reservoir
|
Irrigation of implanted venous access device for drug delivery systems
| 3 |
C0812502::do_not_code_with
|
do_not_code_with
|
Which of the following should not be coded with {subj}?
|
C0812502
|
Laparoscopy, abdomen, peritoneum, and omentum, diagnostic, with or without collection of specimen(s) by brushing or washing (separate procedure)
|
C1736652
|
Laparoscopy, surgical, supracervical hysterectomy, for uterus 250 g or less
|
Total hysterectomy via vaginal approach using intrafascial technique
|
Laparoscopy, surgical, supracervical hysterectomy, for uterus 250 g or less
|
laparoscopic vaginal hysterectomy with repair of cystocele and rectocele
|
laparoscopy with fulguration of gynecologic lesions of uterine surface
| 1 |
C0695240::due_to
|
due_to
|
Which of the following is {subj} due to?
|
C0695240
|
Mechanical complication of gastrostomy
|
C0017196
|
Gastrostomy
|
Gastrostomy
|
Button gastrostomy feeding
|
Hepatogastrostomy
|
Gastroenterostomy
| 0 |
C4040068::due_to
|
due_to
|
Which of the following is {subj} due to?
|
C4040068
|
Hepatic coma due to acute hepatitis C
|
C0400914
|
Acute hepatitis C
|
Hepatitis with hepatic coma
|
Chronic viral hepatitis D
|
Acute hepatitis C
|
Acute hepatopathy
| 2 |
C0410706::due_to
|
due_to
|
Which of the following is {subj} due to?
|
C0410706
|
Osteoporotic kyphosis
|
C0029456
|
Osteoporosis
|
Low turnover osteopathy
|
Osteopenia or osteoporosis
|
Osteoporosis
|
Osteophyte
| 2 |
C3887685::enzyme_metabolizes_chemical_or_drug
|
enzyme_metabolizes_chemical_or_drug
|
Which chemical or drug is metabolized by the enzyme {subj}?
|
C3887685
|
Cytochrome P450 2D6, human
|
C0282321
|
propranolol hydrochloride
|
alprenolol hydrochloride
|
celiprolol hydrochloride
|
tulobuterol hydrochloride
|
propranolol hydrochloride
| 3 |
C0535996::enzyme_metabolizes_chemical_or_drug
|
enzyme_metabolizes_chemical_or_drug
|
Which chemical or drug is metabolized by the enzyme {subj}?
|
C0535996
|
CYP3A5 protein, human
|
C0006462
|
buspirone
|
profenamine
|
buspirone
|
Doprin
|
Buspirone only product
| 1 |
C1142644::enzyme_metabolizes_chemical_or_drug
|
enzyme_metabolizes_chemical_or_drug
|
Which chemical or drug is metabolized by the enzyme {subj}?
|
C1142644
|
cytochrome P450 3A4 protein, human
|
C0085170
|
astemizole
|
astemizole
|
terizidone
|
piminodine
|
tolazamide
| 0 |
C1517178::eo_disease_maps_to_human_disease
|
eo_disease_maps_to_human_disease
|
Which human disease does the experimental organism disease {subj} map to?
|
C1517178
|
Fibroma of the Mouse Skin
|
C0016045
|
fibroma
|
Recurrent fibromatosis
|
Fascial fibroma
|
fibroma
|
fetal myxolipoma
| 2 |
C1522089::eo_disease_maps_to_human_disease
|
eo_disease_maps_to_human_disease
|
Which human disease does the experimental organism disease {subj} map to?
|
C1522089
|
Adenoma of the Mouse Pulmonary System
|
C0001430
|
Adenoma
|
Carcinofibroma
|
Solid carcinoma
|
Adenoma
|
Flat adenoma
| 2 |
C1517177::eo_disease_maps_to_human_disease
|
eo_disease_maps_to_human_disease
|
Which human disease does the experimental organism disease {subj} map to?
|
C1517177
|
Fibroma of the Mouse Intestinal Tract
|
C0017185
|
Gastrointestinal Neoplasms
|
Gastrointestinal Neoplasms
|
Gastrointestinal Carcinoid Tumor
|
Jejunal Neoplasms
|
Gastrointestinal Stromal Tumors
| 0 |
C1826983::exhibited_by
|
exhibited_by
|
Which of the following exhibits {subj}?
|
C1826983
|
5-methyltetrahydrofolate-homocysteine methyltransferase reductase activity
|
C1453956
|
MTRR protein, human
|
MUSK protein, human
|
LTF protein, human
|
MTRR protein, human
|
TPR protein, human
| 2 |
C1149833::exhibited_by
|
exhibited_by
|
Which of the following exhibits {subj}?
|
C1149833
|
feruloyl esterase activity
|
C0117605
|
feruloyl esterase
|
2-ethylmalate synthase
|
vanillyl-alcohol oxidase
|
benzoyl-CoA reductase
|
feruloyl esterase
| 3 |
C1151783::exhibited_by
|
exhibited_by
|
Which of the following exhibits {subj}?
|
C1151783
|
methylenetetrahydrofolate reductase NADPH activity
|
C0066357
|
Methylenetetrahydrofolate reductase (NADPH)
|
Aldose-6-phosphate reductase (NADPH)
|
CoA-disulfide reductase (NADH)
|
Methylenetetrahydrofolate reductase (NADPH)
|
Protein-disulfide reductase (NAD(P)H)
| 2 |
C1439099::exhibits
|
exhibits
|
Which of the following is exhibited by {subj}?
|
C1439099
|
CHST15 protein, human
|
C1325240
|
N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity
|
positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity
|
formate C-acetyltransferase activity
|
UDP-glucose:glycoprotein glucosyltransferase activity
|
N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity
| 3 |
C1456416::exhibits
|
exhibits
|
Which of the following is exhibited by {subj}?
|
C1456416
|
MAPK13 protein, human
|
C1150590
|
SAP kinase 4 activity
|
SAP kinase 4 activity
|
protein kinase A signaling
|
negative regulation of protein kinase B signaling
|
protein kinase regulator activity
| 0 |
C2001855::exhibits
|
exhibits
|
Which of the following is exhibited by {subj}?
|
C2001855
|
EPHX1 protein, human
|
C2247484
|
cis-stilbene-oxide hydrolase activity
|
diacetyl reductase ((R)-acetoin forming) activity
|
cis-stilbene-oxide hydrolase activity
|
5'-hydroxyaverantin dehydrogenase activity
|
all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity
| 1 |
C0585526::finding_method_of
|
finding_method_of
|
Which of the following uses {subj} as a finding method?
|
C0585526
|
Exploration of colon
|
C2182884
|
descending colon procedure manual abdominal exploration noting liver nodules
|
Sigmoid colectomy and exteriorisation of bowel NEC
|
Left hemicolectomy and exteriorisation of bowel NEC
|
descending colon procedure manual abdominal exploration noting liver nodules
|
Emergency excision of abnormal appendix NEC
| 2 |
C1536105::finding_method_of
|
finding_method_of
|
Which of the following uses {subj} as a finding method?
|
C1536105
|
Computed Tomography Angiography
|
C3694981
|
CT angiography of head: aneurysm in right posterior communicating artery
|
CT angiography of head: aneurysm in right posterior communicating artery
|
angiography of cerebral portion of right carotid artery
|
fluoroscopic angiography of cerebral artery and left internal carotid artery
|
fluoroscopic angiography of cerebral artery with right carotid artery with IA contrast
| 0 |
C0412716::finding_method_of
|
finding_method_of
|
Which of the following uses {subj} as a finding method?
|
C0412716
|
Magnetic resonance imaging of ankle
|
C5765162
|
MRI of tibiocalcaneal ligament
|
MRI of calcaneus
|
MRI of acromioclavicular joint
|
MRI of tibiocalcaneal ligament
|
MRI of calcaneus, talus, navicular and cuboid bones of foot
| 2 |
C0032005::finding_site_of
|
finding_site_of
|
Which condition or procedure has {subj} as a finding site?
|
C0032005
|
Pituitary Gland
|
C5568640
|
Xanthomatous hypophysitis
|
Pseudomembranous stomatitis
|
Xanthomatous hypophysitis
|
Palmoplantar hypohidrosis
|
Secondary syphilitic osteopathy
| 1 |
C0000726::finding_site_of
|
finding_site_of
|
Which condition or procedure has {subj} as a finding site?
|
C0000726
|
Abdomen
|
C0206646
|
Fibromatosis, Abdominal
|
Fibromatosis, Abdominal
|
Intra-Abdominal Lymphangioma
|
Endometrioid adenofibroma, malignant
|
Cystadenoma, Papillary
| 0 |
C0700038::finding_site_of
|
finding_site_of
|
Which condition or procedure has {subj} as a finding site?
|
C0700038
|
Female Reproductive System
|
C0346170
|
Serous cystadenoma of ovary
|
Schneiderian carcinoma of cervix
|
Mucinous adenocarcinoma of appendix
|
Serous cystadenoma of ovary
|
Papillary serous cystadenoma
| 2 |
C1706514::gene_associated_with_disease
|
gene_associated_with_disease
|
Which disease is associated with the gene {subj}?
|
C1706514
|
GNAI2 wt Allele
|
C0032000
|
Pituitary Adenoma
|
Childhood Parathyroid Gland Adenoma
|
Pituitary Adenoma
|
Primary pituitary carcinoma
|
Pituitary Neoplasms
| 1 |
C2825749::gene_associated_with_disease
|
gene_associated_with_disease
|
Which disease is associated with the gene {subj}?
|
C2825749
|
MIRLET7G wt Allele
|
C0684249
|
Carcinoma of lung
|
Carcinoma of lung
|
Primary solid carcinoma of lung
|
Carcinoma of upper gum
|
Primary carcinoma of penis
| 0 |
C1416655::gene_associated_with_disease
|
gene_associated_with_disease
|
Which disease is associated with the gene {subj}?
|
C1416655
|
KIT gene
|
C0205851
|
Germ cell tumor
|
Extragonadal primary germ cell cancer
|
Germ cell tumor
|
Ovarian germ cell polyembryoma
|
Testicular gonadoblastoma
| 1 |
C1336804::gene_encodes_gene_product
|
gene_encodes_gene_product
|
Which gene product is encoded by the gene {subj}?
|
C1336804
|
Transforming Growth Factor-Beta Family Gene
|
C0053932
|
Bone Morphogenetic Proteins
|
Eosinophil Major Basic Protein
|
Bone Morphogenetic Proteins
|
MAGE-A1/MAGE-A3/NY-ESO-1 Peptides Vaccine
|
Heparan Sulfate Proteoglycans
| 1 |
C0017362::gene_encodes_gene_product
|
gene_encodes_gene_product
|
Which gene product is encoded by the gene {subj}?
|
C0017362
|
Genes, Regulator
|
C3254737
|
LRRTM2 protein, human
|
SEphB4-HSA
|
BCDX2 Complex
|
rca protein, plant
|
LRRTM2 protein, human
| 3 |
C1334166::gene_encodes_gene_product
|
gene_encodes_gene_product
|
Which gene product is encoded by the gene {subj}?
|
C1334166
|
Immunoprotein Gene
|
C1870106
|
Immunoglobulin Lambda-Like Polypeptide 1, human
|
Virus-specific Hyperimmune Globulins
|
Immune Globulin (Human)
|
Secretory Immunoglobulin A
|
Immunoglobulin Lambda-Like Polypeptide 1, human
| 3 |
C1709988::gene_in_chromosomal_location
|
gene_in_chromosomal_location
|
What is the chromosomal location of the gene {subj}?
|
C1709988
|
SMARCD2 wt Allele
|
C1520781
|
17q23-q24
|
14q23-q24.1
|
3q21-q28
|
17q23-q24
|
4q26-q32
| 2 |
C3538709::gene_in_chromosomal_location
|
gene_in_chromosomal_location
|
What is the chromosomal location of the gene {subj}?
|
C3538709
|
DDX3X wt Allele
|
C1520174
|
Xp11.3-p11.23
|
Xp11.3-p11.23
|
3p24.1-p22
|
1p36.2-p36.12
|
17p11.1
| 0 |
C1705990::gene_in_chromosomal_location
|
gene_in_chromosomal_location
|
What is the chromosomal location of the gene {subj}?
|
C1705990
|
LGALS8 wt Allele
|
C1521015
|
1q42-q43
|
13q12-q13
|
Xq11-q13
|
1q42-q43
|
1p32-q12
| 2 |
C1708291::gene_involved_in_molecular_abnormality
|
gene_involved_in_molecular_abnormality
|
In which molecular abnormality is the gene {subj} involved?
|
C1708291
|
CDC73 gene
|
C1708292
|
CDC73 Gene Mutation
|
CDC73 Gene Mutation
|
PCDH19 gene mutation
|
JAK Family Gene Mutation
|
Non-synonymous JAK Family Gene Mutation
| 0 |
C1335675::gene_involved_in_molecular_abnormality
|
gene_involved_in_molecular_abnormality
|
In which molecular abnormality is the gene {subj} involved?
|
C1335675
|
Receptor Tyrosine Kinase Gene
|
C5447807
|
ERBB2 NM_004448.3:c.2033G>A
|
CYP3A4 gene.c.6C>T
|
Point mutation in exon 21 (L858R)
|
ERBB2 NM_004448.3:c.2033G>A
|
NR5A1 gene mutation
| 2 |
C0919528::gene_involved_in_molecular_abnormality
|
gene_involved_in_molecular_abnormality
|
In which molecular abnormality is the gene {subj} involved?
|
C0919528
|
KMT2A gene
|
C1518132
|
KMT2A-MLLT1 Fusion Protein Expression
|
CDX2 Protein Overexpression
|
KMT2A-MLLT1 Fusion Protein Expression
|
EGFR gene overexpression
|
Non-synonymous RAS Family Gene Mutation
| 1 |
C1537502::gene_involved_in_pathogenesis_of_disease
|
gene_involved_in_pathogenesis_of_disease
|
In the pathogenesis of which disease is the gene {subj} involved?
|
C1537502
|
KRAS gene
|
C1335167
|
mucinous adenocarcinoma of ovary
|
mucinous adenocarcinoma of oral cavity
|
mucinous adenocarcinoma of ovary
|
mucinous adenocarcinoma of anal canal
|
mucinous adenocarcinoma of breast
| 1 |
C0079419::gene_involved_in_pathogenesis_of_disease
|
gene_involved_in_pathogenesis_of_disease
|
In the pathogenesis of which disease is the gene {subj} involved?
|
C0079419
|
TP53 gene
|
C1332166
|
Adenocarcinoma of the gastroesophageal junction
|
Primary carcinoma of lower third of esophagus
|
Adenocarcinoma of the gastroesophageal junction
|
Adenocarcinoma of duodenum
|
Basal cell carcinoma of esophagus
| 1 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.